MAPT and Alzheimer disease: Increased CSF levels of P-tau were found only in patients with AD, while a decrease in Ab42 was found in AD, amyotrophic lateral sclerosis (ALS), CJD, LBD, FTD, multiple system atrophy (MSA) and corticobasal syndrome (CBS) [26,27,28].